Related references
Note: Only part of the references are listed.Intra-airway administration of small interfering RNA targeting plasminogen activator inhibitor-1 attenuates allergic asthma in mice
Shintaro Miyamoto et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2011)
Association of elevated plasminogen activator inhibitor 1 levels with diminished lung function in patients with asthma
Seong Cho et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2011)
Unimpeded skin carcinogenesis in K14-HPV16 transgenic mice deficient for plasminogen activator inhibitor
Anne Masset et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Life-threatening hemorrhage and prolonged wound healing are remarkable phenotypes manifested by complete plasminogen activator inhibitor-1 deficiency in humans
T. Iwaki et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Plasminogen activator inhibitor-1 (PAI-1) is cardioprotective in mice by maintaining microvascular integrity and cardiac architecture
Zhi Xu et al.
BLOOD (2010)
Plasminogen activator inhibitor-1 protects endothelial cells from FasL-mediated apoptosis
Khalid Bajou et al.
CANCER CELL (2008)
The Hemostasis System in Murine Atherosclerosis
Francis Castellino et al.
CURRENT DRUG TARGETS (2008)
Fibrinolysis: The key to new pathogenetic mechanisms
Esther Zorio et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Plasminogen activator inhibitor type 1 deficiency
R. Mehta et al.
HAEMOPHILIA (2008)
Deleterious effects of lack of cardiac PAI-1 after coronary occlusion in mice and their pathophysiologic determinants
A. K. M. Tarikuz Zaman et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2007)
Endogenous urokinase lacks antifibrotic activity during progressive renal injury
Ikuyo Yamaguchi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
Vascular functions of the plasminogen activation system
William P. Fay et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Plasmin(ogen) promotes renal interstitial fibrosis by promoting epithelial-to-mesenchymal transition:: Role of plasmin-activated signals
Guoqiang Zhang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Plasminogen activator inhibitor type 1 is protective during severe Gram-negative pneumonia
Rosemarijn Renckens et al.
BLOOD (2007)
PAI-1 - A potential therapeutic target in cancer
Peter A. Andreasen
CURRENT DRUG TARGETS (2007)
Plasminogen activator inhibitor 1 promotes a poor prognosis in sepsis-induced disseminated intravascular coagulation
Seiji Madoiwa et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2006)
Increased plasminogen activator inhibitor type-1 (PAI-1) in the heart as a function of age
Burton E. Sobel et al.
LIFE SCIENCES (2006)
Insulin resistance increases PAI-1 in the heart
Burton E. Sobel et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Maternal fibrinogen is necessary for embryonic development
T Iwaki et al.
CURRENT DRUG TARGETS (2005)
Multifunctionality of PAI-1 in fibrogenesis:: Evidence from obstructive nephropathy in PAI-1-overexpressing mice
S Matsuo et al.
KIDNEY INTERNATIONAL (2005)
Hypercoagulability in the metabolic syndrome
M Nieuwdorp et al.
CURRENT OPINION IN PHARMACOLOGY (2005)
Plasminogen activator inhibitor-1 in the pathogenesis of asthma
SH Cho et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2004)
Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1
LJ Ma et al.
DIABETES (2004)
Overexpression of urokinase by macrophages or deficiency of plasminogen activator inhibitor type 1 causes cardiac fibrosis in mice
H Moriwaki et al.
CIRCULATION RESEARCH (2004)
Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth
K Bajou et al.
ONCOGENE (2004)
Platelets synthesize large amounts of active plasminogen activator inhibitor 1
H Brogren et al.
BLOOD (2004)
Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1
T Skurk et al.
INTERNATIONAL JOURNAL OF OBESITY (2004)
Fibrinolysis in LPS-induced chronic airway disease
JD Savov et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2003)
Plasminogen activator inhibitor type-1 deficiency does not influence the outcome of murine pneumococcal pneumonia
AW Rijneveld et al.
BLOOD (2003)
Acute release of plasminogen activator inhibitor-1 in ST-segment elevation myocardial infarction predicts mortality
JP Collet et al.
CIRCULATION (2003)
Metastasis of transgenic breast cancer in plasminogen activator inhibitor-1 gene-deficient mice
K Almholt et al.
ONCOGENE (2003)
Myeloperoxidase and plasminogen activator inhibitor 1 play a central role in ventricular remodeling after myocardial infarction
AT Askari et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Nutritionally induced obesity is attenuated in transgenic mice overexpressing plasminogen activator inhibitor-1
HR Lijnen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
The plasmin system in airway remodeling
I Kucharewicz et al.
THROMBOSIS RESEARCH (2003)
Plasminogen activator inhibitor-1 and the kidney
AA Eddy
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2002)
The role of chemokines in linking innate and adaptive immunity
AD Luster
CURRENT OPINION IN IMMUNOLOGY (2002)
Lack of plasminogen activator inhibitor-1 promotes growth and abnormal matrix remodeling of advanced atherosclerotic plaques in apolipoprotein E-deficient mice
A Luttun et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction
T Oda et al.
KIDNEY INTERNATIONAL (2001)
Plasminogen activator inhibitor type 1 enhances neointima formation after oxidative vascular injury in atherosclerosis-prone mice
YH Zhu et al.
CIRCULATION (2001)
LPS induction of gene expression in human monocytes
M Guha et al.
CELLULAR SIGNALLING (2001)
Plasminogen activator inhibitor 1, transforming growth factor-β1, and BMI are closely associated in human adipose tissue during morbid obesity
MC Alessi et al.
DIABETES (2000)
Influence of PAI-1 on adipose tissue growth and metabolic parameters in a murine model of diet-induced obesity
PE Morange et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Atherosclerosis progression in LDL receptor-deficient and apolipoprotein E-deficient mice is independent of genetic alterations in plasminogen activator inhibitor-1
H Sjoland et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Share Paper
